Ask AI
ProCE Banner Events

Share

Conference to Clinic: Expert Analysis of the Top Abstracts From the 2024 Oncology Meeting in Chicago

Join us for this live, interactive webinar to hear experts discuss some of the most impactful abstracts presented during the ASCO Annual Meeting and answer audience questions on the data. Full details on the available topics are provided below.

Physicians: maximum of 5.50 AMA PRA Category 1 Credits™

This event has expired. No longer available for credits.

Who Should Attend

This program is intended for oncologists and other healthcare professionals caring for patients with cancer.

Time and location

Saturday, June 22, 2024

8:00 AM - 4:15 PM Eastern Time (ET)

Virtual

Agenda

Conference to Clinic Live Virtual Webinar

Please note: All times are in ET

8:00 AM - 8:10 AM        Welcome

8:10 AM - 9:40 AM        Hematologic Malignancies - Shaji Kumar, MD; Jeffrey P. Sharman, MD; Eunice S. Wang, MD

9:40 AM - 10:40 AM      Nonaccredited Educational Session, managed by MDOutlook / Clinical Care Solutions, a CEA Company

Treatment and Monitoring of Patients With CML and Ph+ ALL - James McCloskey, MD

Sponsored by: Takeda Oncology

10:40 AM - 10:50 AM    Break

10:50 AM - 11:50 AM    Breast Cancer - Kevin Kalinsky, MD, MS

11:50 AM - 12:00 PM    Break

12:00 PM - 1:00 PM      Nonaccredited Educational Session, managed by MDOutlook / Clinical Care Solutions, a CEA Company

HER2 Expression Informs Eligibility for ENHERTU® in 2L HER2+ or HER2-Low mBC - Maria Theodoulou, MD

Sponsored by: Daiichi Sankyo, Inc and AstraZeneca

1:00 PM - 1:05 PM        Break

1:05 PM - 2:05 PM        Lung Cancer - Zofia Piotrowska, MD

2:05 PM - 3:05 PM        Skin Cancer - Allison Betof Warner, MD

3:05 PM - 3:10 PM       Break

3:10 PM - 4:10 PM       Genitourinary Cancer - Rana R. McKay, MD, FASCO

4:10 PM - 4:15 PM       Concluding Remarks

CME/CE Info

Goal Statement
The goal of this program is to improve learners’ understanding of how to optimally apply recent practice-changing findings in treating patients with solid tumors or hematologic malignancies.

Target Audience
This program is intended for oncologists and other healthcare professionals caring for patients with cancer. 

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Identify subpopulations of patients with solid tumors or hematologic malignancies most likely to benefit from a specific treatment plan based on predictive biomarkers
  • Apply recently presented data to clinical practice to expand treatment options and improve outcomes for patients with solid tumors or hematologic malignancies
  • Evaluate new data on novel agents and therapeutic approaches for patients with solid tumors or hematologic malignancies

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 

Physician Continuing Medical Education

CCO designates this live activity for a maximum of 5.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • Hematologic Malignancies - 1.5
  • Breast Cancer - 1.0
  • Lung Cancer - 1.0
  • Skin Cancer - 1.0
  • Genitourinary cancers - 1.0 

CME Passport

A logo for a companyDescription automatically generated

The CME credits that physicians earn from this activity will be submitted to ACCME's CME Passport, a free, centralized web application where you can create a personalized account to view, track, and generate transcripts of your reported CME credit. Visit www.cmepassport.org to create your account.

Disclosure of Conflicts of Interest
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Acknowledgement

Provided by Clinical Care Options, LLC.

Breast Cancer topic:
Supported by educational grants from AstraZeneca, Daiichi Sankyo, Inc., and Novartis Pharmaceuticals Corporation.

Hematologic Malignancies topic:
Supported by educational grants from GSK, Lilly, Novartis Pharmaceuticals Corporation, and Sanofi.

Lung Cancer topic:
Supported by educational grants from AstraZeneca; Daiichi Sankyo, Inc.; and Gilead Sciences, Inc.

Skin Cancer topic:
Supported by an educational grant from Merck Sharp & Dohme LLC.

Genitourinary Cancer topic:
Supported by an educational grant from Novartis Pharmaceuticals Corporation.

Contact Information

For customer support please click here.

Mailing Address:

 

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 304
Reston, VA 20191

Additional Information

There are no fees required to participate in this activity.

Americans With Disabilities Act 
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact customer support prior to the live event.